A citation-based method for searching scientific literature

Jacopo Boni, Aida Idani, Carla Roca, Lidia Feliubadaló, Eva Tomiak, Evan Weber, William D Foulkes, Alexandre Orthwein, Zaki El Haffaf, Conxi Lazaro, Barbara Rivera. Hum Mutat 2022
Times Cited: 2







List of co-cited articles
articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Evolution of genetic assessment for BRCA-associated gynaecologic malignancies: a Canadian multisociety roadmap.
Jeanna M McCuaig, Tracy L Stockley, Patricia Shaw, Michael Fung-Kee-Fung, Alon D Altman, James Bentley, Marcus Q Bernardini, Beatrice Cormier, Hal Hirte, Katharina Kieser,[...]. J Med Genet 2018
27
50

Reliability of Tumor Testing Compared to Germline Testing for Detecting BRCA1 and BRCA2 Mutations in Patients with Epithelial Ovarian Cancer.
Christine Bekos, Christoph Grimm, Marlene Kranawetter, Stephan Polterauer, Felicitas Oberndorfer, Yen Tan, Leonhard Müllauer, Christian F Singer. J Pers Med 2021
9
50

Mismatch repair and treatment resistance in ovarian cancer.
Jozien Helleman, Iris L van Staveren, Winand N M Dinjens, Patricia F van Kuijk, Kirsten Ritstier, Patricia C Ewing, Maria E L van der Burg, Gerrit Stoter, Els M J J Berns. BMC Cancer 2006
67
50

Inherited Mutations in Women With Ovarian Carcinoma.
Barbara M Norquist, Maria I Harrell, Mark F Brady, Tom Walsh, Ming K Lee, Suleyman Gulsuner, Sarah S Bernards, Silvia Casadei, Qian Yi, Robert A Burger,[...]. JAMA Oncol 2016
430
50

Olaparib Versus Nonplatinum Chemotherapy in Patients With Platinum-Sensitive Relapsed Ovarian Cancer and a Germline BRCA1/2 Mutation (SOLO3): A Randomized Phase III Trial.
Richard T Penson, Ricardo Villalobos Valencia, David Cibula, Nicoletta Colombo, Charles A Leath, Mariusz Bidziński, Jae-Weon Kim, Joo Hyun Nam, Radoslaw Madry, Carlos Hernández,[...]. J Clin Oncol 2020
111
50

A superfamily of conserved domains in DNA damage-responsive cell cycle checkpoint proteins.
P Bork, K Hofmann, P Bucher, A F Neuwald, S F Altschul, E V Koonin. FASEB J 1997
623
50

Cells of origin of ovarian cancer: ovarian surface epithelium or fallopian tube?
Daniel Martin Klotz, Pauline Wimberger. Arch Gynecol Obstet 2017
34
50

PARP Inhibitors in Ovarian Cancer: The Route to "Ithaca".
Stergios Boussios, Afroditi Karathanasi, Deirdre Cooke, Cherie Neille, Agne Sadauskaite, Michele Moschetta, Nikolaos Zakynthinakis-Kyriakou, Nicholas Pavlidis. Diagnostics (Basel) 2019
48
50

High-throughput sequencing of T-cell receptors reveals a homogeneous repertoire of tumour-infiltrating lymphocytes in ovarian cancer.
Ryan O Emerson, Anna M Sherwood, Mark J Rieder, Jamie Guenthoer, David W Williamson, Christopher S Carlson, Charles W Drescher, Muneesh Tewari, Jason H Bielas, Harlan S Robins. J Pathol 2013
114
50

Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer.
Susan J Ramus, Honglin Song, Ed Dicks, Jonathan P Tyrer, Adam N Rosenthal, Maria P Intermaggio, Lindsay Fraser, Aleksandra Gentry-Maharaj, Jane Hayward, Susan Philpott,[...]. J Natl Cancer Inst 2015
249
50

A review on pregnancy complicated by ovarian epithelial and non-epithelial malignant tumors: Diagnostic and therapeutic perspectives.
Stergios Boussios, Michele Moschetta, Konstantina Tatsi, Alexandros K Tsiouris, Nicholas Pavlidis. J Adv Res 2018
27
50

Non-epithelial Ovarian Cancer: Elucidating Uncommon Gynaecological Malignancies.
Stergios Boussios, George Zarkavelis, Esmeralda Seraj, Ioannis Zerdes, Konstantina Tatsi, George Pentheroudakis. Anticancer Res 2016
31
50

Uptake of clinical genetic testing for ovarian cancer in Ontario: a population-based study.
Kelly A Metcalfe, Isabel Fan, John McLaughlin, Harvey A Risch, Barry Rosen, Joan Murphy, Linda Bradley, Susan Armel, Ping Sun, Steven A Narod. Gynecol Oncol 2009
46
50

Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
Douglas K Owens, Karina W Davidson, Alex H Krist, Michael J Barry, Michael Cabana, Aaron B Caughey, Chyke A Doubeni, John W Epling, Martha Kubik, C Seth Landefeld,[...]. JAMA 2019
191
50

Two Swedish founder MSH6 mutations, one nonsense and one missense, conferring high cumulative risk of Lynch syndrome.
K Cederquist, M Emanuelsson, F Wiklund, I Golovleva, R Palmqvist, H Grönberg. Clin Genet 2005
34
50

Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline.
Panagiotis A Konstantinopoulos, Barbara Norquist, Christina Lacchetti, Deborah Armstrong, Rachel N Grisham, Paul J Goodfellow, Elise C Kohn, Douglas A Levine, Joyce F Liu, Karen H Lu,[...]. J Clin Oncol 2020
119
50

Frequency of mutations in a large series of clinically ascertained ovarian cancer cases tested on multi-gene panels compared to reference controls.
Jenna Lilyquist, Holly LaDuca, Eric Polley, Brigette Tippin Davis, Hermela Shimelis, Chunling Hu, Steven N Hart, Jill S Dolinsky, Fergus J Couch, David E Goldgar. Gynecol Oncol 2017
69
50

Are surveillance procedures of clinical benefit for patients treated for ovarian cancer?: A retrospective Italian multicentric study.
Angiolo Gadducci, Luca Fuso, Stefania Cosio, Fabio Landoni, Tiziano Maggino, Stefania Perotto, Enrico Sartori, Antonia Testa, Luciano Galletto, Paolo Zola. Int J Gynecol Cancer 2009
48
50

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
50

Domain mapping of the Rad51 paralog protein complexes.
Kristi A Miller, Dorota Sawicka, Daniel Barsky, Joanna S Albala. Nucleic Acids Res 2004
64
50

Homologous recombination in DNA repair and DNA damage tolerance.
Xuan Li, Wolf-Dietrich Heyer. Cell Res 2008
567
50

Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer.
Kelly L Bolton, Georgia Chenevix-Trench, Cindy Goh, Siegal Sadetzki, Susan J Ramus, Beth Y Karlan, Diether Lambrechts, Evelyn Despierre, Daniel Barrowdale, Lesley McGuffog,[...]. JAMA 2012
415
50

ColoSeq provides comprehensive lynch and polyposis syndrome mutational analysis using massively parallel sequencing.
Colin C Pritchard, Christina Smith, Stephen J Salipante, Ming K Lee, Anne M Thornton, Alex S Nord, Cassandra Gulden, Sonia S Kupfer, Elizabeth M Swisher, Robin L Bennett,[...]. J Mol Diagn 2012
148
50

The contribution of deleterious germline mutations in BRCA1, BRCA2 and the mismatch repair genes to ovarian cancer in the population.
Honglin Song, Mine S Cicek, Ed Dicks, Patricia Harrington, Susan J Ramus, Julie M Cunningham, Brooke L Fridley, Jonathan P Tyrer, Jennifer Alsop, Mercedes Jimenez-Linan,[...]. Hum Mol Genet 2014
85
50

Epithelial ovarian cancer.
Stephanie Lheureux, Charlie Gourley, Ignace Vergote, Amit M Oza. Lancet 2019
641
50

Ovarian sex-cord stromal tumours and small cell tumours: Pathological, genetic and management aspects.
Stergios Boussios, Michele Moschetta, George Zarkavelis, Alexandra Papadaki, Aristides Kefas, Konstantina Tatsi. Crit Rev Oncol Hematol 2017
29
50

Tumor BRCA Test for Patients with Epithelial Ovarian Cancer: The Role of Molecular Pathology in the Era of PARP Inhibitor Therapy.
Caterina Fumagalli, Federica Tomao, Ilaria Betella, Alessandra Rappa, Mariarosaria Calvello, Bernardo Bonanni, Loris Bernard, Fedro Peccatori, Nicoletta Colombo, Giuseppe Viale,[...]. Cancers (Basel) 2019
19
50

Deficiency in the repair of DNA damage by homologous recombination and sensitivity to poly(ADP-ribose) polymerase inhibition.
Nuala McCabe, Nicholas C Turner, Christopher J Lord, Katarzyna Kluzek, Aneta Bialkowska, Sally Swift, Sabrina Giavara, Mark J O'Connor, Andrew N Tutt, Małgorzata Z Zdzienicka,[...]. Cancer Res 2006
921
50

A Cost-effectiveness Analysis of Multigene Testing for All Patients With Breast Cancer.
Li Sun, Adam Brentnall, Shreeya Patel, Diana S M Buist, Erin J A Bowles, D Gareth R Evans, Diana Eccles, John Hopper, Shuai Li, Melissa Southey,[...]. JAMA Oncol 2019
69
50

DNA methylation: an alternative pathway to cancer.
S A Wajed, P W Laird, T R DeMeester. Ann Surg 2001
192
50

BRCA mutation in high grade epithelial ovarian cancers.
Tarinee Manchana, Natacha Phoolcharoen, Patou Tantbirojn. Gynecol Oncol Rep 2019
33
50


Frequency of germline PALB2 mutations among women with epithelial ovarian cancer.
Joanne Kotsopoulos, Victoria Sopik, Barry Rosen, Isabel Fan, John R McLaughlin, Harvey Risch, Ping Sun, Steven A Narod, Mohammad R Akbari. Fam Cancer 2017
17
50

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.
D Ford, D F Easton, M Stratton, S Narod, D Goldgar, P Devilee, D T Bishop, B Weber, G Lenoir, J Chang-Claude,[...]. Am J Hum Genet 1998
50

The evolution of cancer risk assessment in the era of next generation sequencing.
Heather Fecteau, Kristen J Vogel, Kristen Hanson, Shannon Morrill-Cornelius. J Genet Couns 2014
48
50

Advances in synthetic lethality for cancer therapy: cellular mechanism and clinical translation.
Win Topatana, Sarun Juengpanich, Shijie Li, Jiasheng Cao, Jiahao Hu, Jiyoung Lee, Kenneth Suliyanto, Diana Ma, Bin Zhang, Mingyu Chen,[...]. J Hematol Oncol 2020
45
50

Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing.
Tom Walsh, Silvia Casadei, Ming K Lee, Christopher C Pennil, Alex S Nord, Anne M Thornton, Wendy Roeb, Kathy J Agnew, Sunday M Stray, Anneka Wickramanayake,[...]. Proc Natl Acad Sci U S A 2011
654
50

Rethinking ovarian cancer: recommendations for improving outcomes.
Sebastian Vaughan, Jermaine I Coward, Robert C Bast, Andy Berchuck, Jonathan S Berek, James D Brenton, George Coukos, Christopher C Crum, Ronny Drapkin, Dariush Etemadmoghadam,[...]. Nat Rev Cancer 2011
890
50

Genetic epidemiology of ovarian cancer and prospects for polygenic risk prediction.
Michelle R Jones, Daniella Kamara, Beth Y Karlan, Paul D P Pharoah, Simon A Gayther. Gynecol Oncol 2017
49
50

Non-Epithelial Ovarian Cancers: How Much Do We Really Know?
Alison Cheung, Sidrah Shah, Jack Parker, Pavandeep Soor, Anu Limbu, Matin Sheriff, Stergios Boussios. Int J Environ Res Public Health 2022
12
50

Veliparib in ovarian cancer: a new synthetically lethal therapeutic approach.
Stergios Boussios, Peeter Karihtala, Michele Moschetta, Charlotte Abson, Afroditi Karathanasi, Nikolaos Zakynthinakis-Kyriakou, Jake Edward Ryan, Matin Sheriff, Elie Rassy, Nicholas Pavlidis. Invest New Drugs 2020
56
50

Ovarian cancer risk assessment in the era of next-generation sequencing.
Renata Colombo Bonadio, Jéssica Rojas Crespo, Maria Del Pilar Estevez-Diz. Ann Transl Med 2020
1
100

Homologous recombination deficiency in ovarian cancer: a review of its epidemiology and management.
Renata Rodrigues da Cunha Colombo Bonadio, Rodrigo Nogueira Fogace, Vanessa Costa Miranda, Maria Del Pilar Estevez Diz. Clinics (Sao Paulo) 2018
65
50

Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers.
Peter C Fong, David S Boss, Timothy A Yap, Andrew Tutt, Peijun Wu, Marja Mergui-Roelvink, Peter Mortimer, Helen Swaisland, Alan Lau, Mark J O'Connor,[...]. N Engl J Med 2009
50

Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer.
Mansoor R Mirza, Bradley J Monk, Jørn Herrstedt, Amit M Oza, Sven Mahner, Andrés Redondo, Michel Fabbro, Jonathan A Ledermann, Domenica Lorusso, Ignace Vergote,[...]. N Engl J Med 2016
50

Prognostic significance of tumor-infiltrating T cells in ovarian cancer: a meta-analysis.
Wei-Ting Hwang, Sarah F Adams, Emin Tahirovic, Ian S Hagemann, George Coukos. Gynecol Oncol 2012
424
50

Germline mutations in RAD51D confer susceptibility to ovarian cancer.
Chey Loveday, Clare Turnbull, Emma Ramsay, Deborah Hughes, Elise Ruark, Jessica R Frankum, Georgina Bowden, Bolot Kalmyrzaev, Margaret Warren-Perry, Katie Snape,[...]. Nat Genet 2011
352
50

Frequency of mutations in mismatch repair genes in a population-based study of women with ovarian cancer.
T Pal, M R Akbari, P Sun, J-H Lee, J Fulp, Z Thompson, D Coppola, S Nicosia, T A Sellers, J McLaughlin,[...]. Br J Cancer 2012
59
50


Tumor infiltrating lymphocytes in ovarian cancer.
Phillip P Santoiemma, Daniel J Powell. Cancer Biol Ther 2015
194
50


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.